Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Medical Inc (NQ: NMRD )

0.1053 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nemaura Medical Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday. 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Receives Provisional Purchase Order from Middle East Licensee
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical: Q4 Earnings Insights
Nemaura Medical (NASDAQ:NMRD) reported its Q4 earnings results on Thursday, June 30, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
From Nemaura Medical, Inc
Via GlobeNewswire
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Inventiva (NASDAQ:IVA) shares increased by 44.0% to $5.88 during Friday's regular session. The market value of their outstanding shares is at $247.6 million. 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming MicroCap Rodeo Windy City Roundup
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Glyphosate
Nemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
From Nemaura Medical, Inc
Via GlobeNewswire
EVERSANA signs preliminary agreement for the large-scale launch of NMRD’s Diabetes Management Program in the U.S. Nemaura Medical, Inc. (NASDAQ: NMRD)
Via Get News
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Collaborates with EVERSANA(R) to Bring BEATdiabetes Solution to Market
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago
Via ACCESSWIRE
Commercial Advancements in Non-Invasive Wearable Diagnostic Devices for Diabetes Management and Metabolic Wellness: Nemaura Medical, Inc. (NASDAQ: NMRD)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Apple To $185? Here Are 5 Other Price Target Changes For Friday
Keybanc raised the price target on Apple Inc. (NASDAQ: AAPL) from $177 to $185. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.9% to $172.63 in... 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q1 2023 Report, Notes Purchase Agreement Highlight
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recap: Nemaura Medical Q1 Earnings
  Nemaura Medical (NASDAQ:NMRD) reported its Q1 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Nemaura Medical reported... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Featured in Bell2Bell Podcast
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures UK Trademark for ‘Meta Score’
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nasdaq Turns Higher; Rubicon Technology Shares Jump
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite turning higher later on Tuesday. 
Via Benzinga
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter. 
Via Benzinga
Nemaura Medical's Return On Capital Employed Insights
Nemaura Medical (NASDAQ:NMRD) brought in sales totaling $320.28 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 5.41%, resulting in a loss of $3.62 million. 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Financial Report, Corporate Updates
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures $5M in Non-Dilutive Funding
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate in H.C. Wainwright Global Hybrid Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.